Stenocare A/S (CPSE: STENO)
Health Care · Pharmaceuticals · DK
Dkr0.98
-0.61% today · -20.8% 1Y
Stenocare A/S (CPSE: STENO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.68M and employs 4 people.
Over the last twelve months the share price has lost 20.8%, trading between 0.79 and 2.80.
Tweenvest scores Stenocare A/S across four factors: quality 20/100, value 77/100. Its strongest factor is value.
STENO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.68M
- Revenue (TTM)
- $1.76M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- Dkr2.80
- 52-week low
- Dkr0.79
- Avg volume (3M)
- —
- Shares outstanding
- 43.20M
- Employees
- 4
- Next earnings
- —
About Stenocare A/S
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
- ISIN
- DK0061078425
- Founded
- 2017
- Listed since
- May 18, 2020
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.